1.重庆医科大学附属第二医院肿瘤中心,重庆 401336
2.中国医学科学院北京协和医学院放射医学研究所/天津放射医学和分子核医学重点实验室,天津 300110
3.天津医科大学肿瘤放疗科/国家癌症研究中心/天津市癌症临床研究中心/肿瘤预防和治疗重点实验室,天津 300060
Received:23 July 2024,
Published:25 March 2025
移动端阅览
杨钰嫣,姚尧,夏蕾.阴囊Paget病1例[J].局解手术学杂志,2025,34(03):275-276.
YANG Yu-yan,YAO Yao,XIA Lei.Penoscrotal Paget's disease: a case report[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2025,34(03):275-276.
杨钰嫣,姚尧,夏蕾.阴囊Paget病1例[J].局解手术学杂志,2025,34(03):275-276. DOI: 10.11659/jjssx.07E024124.
YANG Yu-yan,YAO Yao,XIA Lei.Penoscrotal Paget's disease: a case report[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2025,34(03):275-276. DOI: 10.11659/jjssx.07E024124.
聂廷芬 , 周之海 . 乳房外Paget病免疫组化研究进展 [J]. 国际皮肤性病学杂志 , 2007 , 33 ( 5 ): 308 - 310 . doi: 10.3760/cma.j.issn.1673-4173.2007.05.016 http://dx.doi.org/10.3760/cma.j.issn.1673-4173.2007.05.016 .
Dauendorffer JN , Herms F , Baroudjian B , et al . Penoscrotal Paget's disease [J]. Ann Dermatol Venereol , 2021 , 148 ( 2 ): 71 - 76 . doi: 10.1016/j.annder.2020.08.051 http://dx.doi.org/10.1016/j.annder.2020.08.051 .
薛姣龙 . 乳房和乳房外Paget病临床分析及COX-2、HER2等蛋白的研究 [D]. 济南 : 山东大学 , 2014 .
Carton I , Lebreton M , Tesson C , et al . Paget's disease of the vulva: a challenge for the gynaecologist [J]. J Gynecol Obstet Hum Reprod , 2021 , 50 ( 1 ): 101896 . doi: 10.1016/j.jogoh.2020.101896 http://dx.doi.org/10.1016/j.jogoh.2020.101896 .
Do J , Do SI , Kim HS . Identification of predictive factors for post-operative recurrence and clinical outcomes of primary vulvar extramammary Paget disease [J]. In Vivo , 2023 , 37 ( 6 ): 2618 - 2627 . doi: 10.21873/invivo.13369 http://dx.doi.org/10.21873/invivo.13369 .
Ren F , Zhao S , Yang C , et al . Applications of photodynamic therapy in extramammary Paget's disease [J]. Am J Cancer Res , 2023 , 13 ( 10 ): 4492 - 4507 .
Damavandy AA , Terushkin V , Zitelli JA , et al . Intraoperative immunostaining for cytokeratin-7 during Mohs micrographic surgery demonstrates low local recurrence rates in extramammary Paget's disease [J]. Dermatol Surg , 2018 , 44 ( 3 ): 354 - 364 . doi: 10.1097/DSS.0000000000001355 http://dx.doi.org/10.1097/DSS.0000000000001355 .
Zhu H , Lewis DJ . Efficacy of trastuzumab in HER-2-positive advanced extramammary Paget's disease [J]. Expert Opin Biol Ther , 2022 , 22 ( 5 ): 673 - 674 . doi: 10.1080/14712598.2022.2066472 http://dx.doi.org/10.1080/14712598.2022.2066472 .
Plaza JA , Torres-Cabala C , Ivan D , et al . HER-2/neu expression in extramammary Paget disease: a clinicopathologic and immunohistochemistry study of 47 cases with and without underlying malignancy [J]. J Cutan Pathol , 2009 , 36 ( 7 ): 729 - 733 . doi: 10.1111/j.1600-0560.2008.01148.x http://dx.doi.org/10.1111/j.1600-0560.2008.01148.x .
Ichiyama T , Gomi D , Fukushima T , et al . Successful and long-term response to trastuzumab plus paclitaxel combination therapy in human epidermal growth factor receptor 2-positive extramammary Paget's disease: a case report and review of the literature [J]. Mol Clin Oncol , 2017 , 7 ( 5 ): 763 - 766 . doi: 10.3892/mco.2017.1422 http://dx.doi.org/10.3892/mco.2017.1422 .
Nowicka-Matus K , Salkus G , Sønderkær M , et al . Scrotal Paget's disease associated with human epidermal growth factor receptor 2-overexpressing metastatic apocrine carcinoma with complete response to paclitaxel, trastuzumab, and pertuzumab [J]. JCO Precis Oncol , 2023 , 7 : e2300173 . doi: 10.1200/PO.23.00173 http://dx.doi.org/10.1200/PO.23.00173 .
0
Views
0
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621
